By Melodie Holden | Vice President
In the spring of 2006, traditional midwives from the rural Tigray region of Ethiopia were trained to administer misoprostol to women after delivery during home births. The off-patent drug is used for controlling postpartum hemorrhage, the leading cause of maternal death. By September 2006, the study had been implemented in over 100 births. Early results show that traditional midwives are capable of safely and effectively providing this life-saving drug to their clients. The Ethiopian doctor heading the study recently visited one of the villages where the drug was in use. As he arrived, he was surprised to be surrounded by women singing and dancing, a spontaneous welcome party. "We are so grateful to have this drug at home," they sang. Venture Strategies is proud to be a part of this demonstration project with the Ethiopian Ministry of Health.
Project reports on GlobalGiving are posted directly to globalgiving.org by Project Leaders as they are completed, generally every 3-4 months. To protect the integrity of these documents, GlobalGiving does not alter them; therefore you may find some language or formatting issues.
If you donate to this project or have donated to this project, you can receive an email when this project posts a report. You can also subscribe for reports without donating.
